Sioban B. Keel

Hematology

825 Eastlake Ave E
Seattle, WA 98109

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

A quantitative definition of the clinical manifestations of GATA2 deficiency in adults.

A quantitative definition of the clinical manifestations of GATA2 deficiency in adults.

Journal: Blood

Published: May 18, 2026

Comparison of Late Effects and Quality of Life by Donor Type in Long-Term Survivors of Severe Aplastic Anemia after Hematopoietic Cell Transplantation.

Comparison of Late Effects and Quality of Life by Donor Type in Long-Term Survivors of Severe Aplastic Anemia after Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: April 17, 2026

Impact of horse anti-thymocyte globulin on graft-versus-host disease after human leukocyte antigen-matched related bone marrow transplantation for severe aplastic anemia.

Impact of horse anti-thymocyte globulin on graft-versus-host disease after human leukocyte antigen-matched related bone marrow transplantation for severe aplastic anemia.

Journal: Haematologica

Published: February 18, 2026

Accessibility and harmonization of biochemical tests for diagnosis and monitoring of Porphyrias in the United States: Recommendations by members of the American Porphyrias Expert Collaborative (APEX).

Accessibility and harmonization of biochemical tests for diagnosis and monitoring of Porphyrias in the United States: Recommendations by members of the American Porphyrias Expert Collaborative (APEX).

Journal: Molecular genetics and metabolism

Published: February 17, 2026

Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.

Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms.

Journal: Leukemia

Published: January 16, 2026

Allogeneic Hematopoietic Cell Transplantation for Aplastic Anemia: A Single Institution Experience Across Six Decades.

Allogeneic Hematopoietic Cell Transplantation for Aplastic Anemia: A Single Institution Experience Across Six Decades.

Journal: Blood advances

Published: September 29, 2025

Allogeneic hematopoietic cell transplantation for aplastic anemia: a single institution experience across 6 decades.

Allogeneic hematopoietic cell transplantation for aplastic anemia: a single institution experience across 6 decades.

Journal: Blood advances

Published: September 29, 2025

Lymphoid malignancy and clonality in the POT1-mediated long telomere syndrome.

Lymphoid malignancy and clonality in the POT1-mediated long telomere syndrome.

Journal: Blood

Published: August 26, 2025

Addition of ADAMTS13 testing to cryptogenic stroke evaluation: index case and single-center screening initial experience.

Addition of ADAMTS13 testing to cryptogenic stroke evaluation: index case and single-center screening initial experience.

Journal: Blood advances

Published: July 16, 2025

Bitopertin shows efficacy in patients with erythropoietic protoporphyria: Results from the randomized, double-blind, placebo-controlled AURORA trial.

Bitopertin shows efficacy in patients with erythropoietic protoporphyria: Results from the randomized, double-blind, placebo-controlled AURORA trial.

Journal: Journal of the American Academy of Dermatology

Published: June 17, 2025

Genetics of interstitial lung diseases: a state-of-the-art review.

Genetics of interstitial lung diseases: a state-of-the-art review.

Journal: The European respiratory journal

Published: April 13, 2025

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025.

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: March 12, 2025

Showing 1-12 of 68

Last Updated: 09/26/2026